Astrana Health, Inc.
DE ˙ DB ˙ US03763A2078
31,20 € ↓ -0,40 (-1,27%)
2026-06-03
AKTIENPREIS
SecurityDE:3AM / Astrana Health, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in 3AM / Astrana Health, Inc.

2026-03-26 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Astrana Health, Inc. (DE:3AM). This represents 0.0 percent ownership of the company. In their previous filing dated 2026-01-30 , Vanguard Group Inc had reported owning 4,238,192 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-03-26 2026-03-26 13G/A 4,238,192 0 -100.00 0.00 -100.00
2026-01-30 2026-01-30 13G/A 4,833,384 4,238,192 -12.31 8.45 -12.71
2025-07-29 2025-07-29 13G/A 5,049,928 4,833,384 -4.29 9.68 11.78
2024-02-13 2024-02-13 13G/A 4,438,955 5,049,928 13.76 8.66 10.60
2023-02-09 2023-02-09 13G/A 3,897,315 4,438,955 13.90 7.83 11.54
2022-02-09 2022-02-09 13G 3,897,315 7.02

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F ASTRANA HEALTH COM NEW 03763A207 4,238,192 -482,884 -10.23 105,150 -21.44 0.0015
2025-11-07 2025-09-30 13F ASTRANA HEALTH COM NEW 03763A207 4,721,076 -112,308 -2.32 133,843 11.30 0.0020
2025-08-11 2025-06-30 13F ASTRANA HEALTH COM NEW 03763A207 4,833,384 -65,608 -1.34 120,255 -20.84 0.0019
2025-05-09 2025-03-31 13F ASTRANA HEALTH COM NEW 03763A207 4,898,992 213,033 4.55 151,918 2.82 0.0027
2025-02-11 2024-12-31 13F ASTRANA HEALTH COM NEW 03763A207 4,685,959 20,757 0.44 147,748 -45.34 0.0026
2024-11-13 2024-09-30 13F ASTRANA HEALTH COM NEW 03763A207 4,665,202 -52,885 -1.12 270,302 41.25 0.0048
2024-08-13 2024-06-30 13F ASTRANA HEALTH COM NEW 03763A207 4,718,087 -342,123 -6.76 191,366 -9.94 0.0037
2024-05-10 2024-03-31 13F ASTRANA HEALTH COM NEW 03763A207 5,060,210 10,282 0.20 212,478 9.86 0.0042
2024-03-11 2023-12-31 13F/A-1 APOLLO MED HLDGS COM NEW 03763A207 5,049,928 260,687 5.44 193,412 30.91 0.0042
2024-02-14 2023-12-31 13F APOLLO MED HLDGS COM NEW 03763A207 5,049,928 260,687 193,412 0.0037
2023-12-18 2023-09-30 13F/A-1 APOLLO MED HLDGS COM NEW 03763A207 4,789,241 43,714 0.92 147,748 -1.47 0.0036
2023-11-14 2023-09-30 13F APOLLO MED HLDGS COM NEW 03763A207 4,789,241 43,714 147,748 0.0007
2023-08-14 2023-06-30 13F APOLLO MED HLDGS COM NEW 03763A207 4,745,527 32,257 0.68 149,959 -12.76 0.0036
2023-07-14 2023-03-31 13F/A-1 APOLLO MED HLDGS COM NEW 03763A207 4,713,270 274,315 6.18 171,893 30.87 0.0044
2023-05-15 2023-03-31 13F APOLLO MED HLDGS COM NEW 03763A207 4,713,270 274,315 171,893 0.0044
2023-02-10 2022-12-31 13F APOLLO MED HLDGS COM NEW 03763A207 4,438,955 172,563 4.04 131,349 -21.06 0.0036
2022-11-14 2022-09-30 13F APOLLO MED HLDGS COM NEW 03763A207 4,266,392 66,735 1.59 166,389 2.67 0.0049
2022-08-12 2022-06-30 13F APOLLO MED HLDGS COM NEW 03763A207 4,199,657 273,681 6.97 162,066 -14.83 0.0046
2022-05-13 2022-03-31 13F APOLLO MED HLDGS COM NEW 03763A207 3,925,976 28,661 0.74 190,293 -33.55 0.0045
2022-02-14 2021-12-31 13F APOLLO MED HLDGS COM NEW 03763A207 3,897,315 750,357 23.84 286,375 -0.05 0.0065
2021-11-12 2021-09-30 13F APOLLO MED HLDGS COM NEW 03763A207 3,146,958 1,410,547 81.23 286,530 162.72 0.0071
2021-08-13 2021-06-30 13F APOLLO MED HLDGS COM NEW 03763A207 1,736,411 463,617 36.43 109,064 216.31 0.0027
2021-05-14 2021-03-31 13F APOLLO MED HLDGS COM NEW 03763A207 1,272,794 19,007 1.52 34,480 50.53 0.0009
2021-02-12 2020-12-31 13F APOLLO MED HLDGS COM NEW 03763A207 1,253,787 45,626 3.78 22,906 5.67 0.0007
2020-11-16 2020-09-30 13F APOLLO MED HLDGS COM NEW 03763A207 1,208,161 -149,231 -10.99 21,676 -3.21 0.0007
2020-08-14 2020-06-30 13F APOLLO MED HLDGS COM NEW 03763A207 1,357,392 590,536 77.01 22,396 126.06 0.0008
2020-05-15 2020-03-31 13F APOLLO MED HLDGS COM NEW 03763A207 766,856 -101,830 -11.72 9,907 -38.05 0.0004
2020-02-14 2019-12-31 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 868,686 -405,969 -31.85 15,992 -28.79 0.0005
2019-11-14 2019-09-30 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 1,274,655 109,828 9.43 22,459 15.39 0.0008
2019-08-14 2019-06-30 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 1,164,827 102,267 9.62 19,464 -0.01 0.0007
2019-05-15 2019-03-31 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 1,062,560 97,380 10.09 19,466 1.60 0.0008
2019-02-14 2018-12-31 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 965,180 36,269 3.90 19,159 -6.55 0.0009
2018-12-13 2018-09-30 13F/A-2 APOLLO MEDICAL HLDGS COM NEW 03763A207 928,911 602,710 184.77 20,501 143.05 0.0008
2018-11-23 2018-09-30 13F/A-1 APOLLO MEDICAL HLDGS COM NEW 03763A207 928,911 0 20,501 0.0008
2018-11-14 2018-09-30 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 928,911 602,710 20,501
2018-08-14 2018-06-30 13F APOLLO MEDICAL HLDGS COM NEW 03763A207 326,201 326,201 8,435 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.